..Осуждать её за то, что она сделала - глупо, но советовать другим поступать так-же ещё глупее.
О! У неё есть деньги. НЕЛьЗЯ всем это советовать хотя-бы поэтому - у людей нет таких возможностей. Страховка (большинство) не покроет операцию НЕ ПО ПОКАЗАНИЯМ, а из-за предрасположенности.
если я или вы будем кому-то советовать такую операцию, то будет, действительно, глупо.
Но если это делает врач, да не один, то глупостью будет к такому совету не прислушаться.
Относительно "страховка не покроет" -
ЛОЖЬ:
Aetna considers prophylactic mastectomy medically necessary for reduction of risk of breast cancer in any of the following categories of high-risk women:
Women diagnosed with breast cancer at 45 years of age or younger; or
Women who are at increased risk for specific mutation(s) due to ethnic background (for instance: Ashkenazi Jewish descent) and who have 1 or more relatives with breast cancer or epithelial ovarian cancer at any age; or
Women who carry a genetic mutation in the TP53 or PTEN genes (Li-Fraumeni syndrome and Cowden and Bannayan-Riley-Ruvalcaba syndromes); or
Women who possess BRCA1 or BRCA2 mutations confirmed by molecular susceptibility testing for breast and/or epithelial ovarian cancer; or
Women who received radiation treatment to the chest between ages of 10 and 30 years, such as for Hodgkin disease; or
Women with a 1st- or 2nd-degree male relative with breast cancer*; or
Women with multiple primary or bilateral breast cancers in a 1st- or 2nd-degree blood relative; or
Women with multiple primary or bilateral breast cancers; or
Women with 1 or more cases of epithelial ovarian cancer AND 1 or more 1st- or 2nd-degree blood relatives on the same side of the family with breast cancer; or
Women with 3 or more affected 1st- or 2nd-degree blood relatives on the same side of the family, irrespective of age at diagnosis.
Aetna considers prophylactic bilateral oophorectomy or salpingo-oophorectomy medically necessary in selected women with risk factors for epithelial ovarian carcinoma -- including nulliparity, low parity, infertility, early menarche, late menopause, and late first pregnancy -- if they meet any of the following criteria:
Women who are beyond child-bearing age (40 years of age or older) who have been diagnosed with an hereditary epithelial ovarian cancer syndrome based on a family pedigree constructed by a genetic counselor or physician competent in determining the presence of an autosomal dominant inheritance pattern; or
Women who have 2 1st-degree relatives (e.g., mother, sister, daughter) with a history of epithelial ovarian cancer; or
Women with a personal history of breast cancer and at least 1 1st-degree relative (e.g., mother, sister, daughter) with history of epithelial ovarian cancer; or
Women with BRCA1 or BRCA2 mutations confirmed by molecular susceptibility testing; or
Women with 1 1st-degree relative (e.g., mother, sister, daughter) and 1 or more 2nd-degree relatives (e.g., maternal or paternal aunt, grandmother, niece) with epithelial ovarian cancer.